Urence Pharma(India)Private Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2016
- Satisfied Charges ₹ 2.30 M
- Revenue Growth -67.74%
- Profit Growth -64.82%
- Ebitda
- Net Worth 113.67%
- Total Assets -73.58%
About Urence Pharma(India)Private
Company Details
- Location
Cuttack, Odisha, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397OR2007PTC009308
- Company No.
009308
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2007
- Date of AGM
29 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc-Cuttack
Industry
Who are the key members and board of directors at Urence Pharma(India)Private?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmendra Samal  | Managing Director | 10-Mar-2011 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jnanendra Samal | Director | 30-Apr-2007 | Current |
Financial Performance of Urence Pharma(India)Private.
Urence Pharma(India)Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 67.74% decrease. The company also saw a substantial fall in profitability, with a 64.82% decrease in profit. The company's net worth Soared by an impressive increase of 113.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Urence Pharma(India)Private?
In 2016, Urence Pharma(India)Private had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹2.30 M
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2008 | Syndicate Bank | ₹2.30 M | Satisfied |
How Many Employees Work at Urence Pharma(India)Private?
Unlock and access historical data on people associated with Urence Pharma(India)Private, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Urence Pharma(India)Private, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urence Pharma(India)Private's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
